Top Biotechnology companies in United States by Net Income

This ranking features the top 510 Biotechnology companies in United States ranked by Net Income, totaling a Net Income of USD 44.96 B, for June 24, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 … 11

Frequently Asked Questions

Which Biotechnology company in United States has the highest Net Income ?

The Biotechnology company in United States with the highest Net Income is Merck & Co., Inc. (NYSE: MRK) at USD 17.43 B.
Which Biotechnology company in United States has the lowest Net Income ?

The Biotechnology company in United States with the lowest Net Income is Anika Therapeutics, Inc. (NasdaqGS: ANIK) at None.

What are the top 10 Biotechnology companies in United States by Net Income ?

The top 10 Biotechnology companies in United States by Net Income are Merck & Co., Inc., Abbott Laboratories, Pfizer Inc., Thermo Fisher Scientific Inc., Gilead Sciences, Inc., Amgen Inc., Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Inc., AbbVie Inc. and Danaher Corporation.
What are the bottom 10 Biotechnology companies in United States by Net Income ?

The bottom 10 Biotechnology companies in United States by Net Income are Anika Therapeutics, Inc., Autonomix Medical, Inc. Common Stock, Aldeyra Therapeutics, Inc., Amylyx Pharmaceuticals, Inc., Aditxt, Inc., Allogene Therapeutics, Inc., Adverum Biotechnologies, Inc., ABVC BioPharma, Inc., Adagio Medical Holdings, Inc. and Anixa Biosciences, Inc..